Safety, tolerability, and concordance with interferon-γ release assays of a recombinant ESAT6–MPT64 skin test: a phase 1 randomized clinical trial
BackgroundAccurate and cost-effective screening for Mycobacterium tuberculosis (Mtb) infection remains a global challenge. While Interferon-γ Release Assays (IGRAs) offer high specificity, their widespread deployment is hindered by high costs and techn…